Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Scott Brockenbrough

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nucleosides, Nucleotides & Nucleic Acids|April 15, 2010
Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP)John R Grierson, J Scott Brockenbrough, Janet S Rasey, et al.
Nuclear Medicine and Biology|August 21, 2007
A simple quantitative assay for the activity of thymidine kinase 1 in solid tumorsJ Scott Brockenbrough, Janet S Rasey, John R Grierson, et al.
Nuclear Medicine and Biology|June 27, 2007
Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activityJohn R Grierson, J Scott Brockenbrough, Janet S Rasey, et al.
Journal of the American Medical Informatics Association : JAMIA|April 27, 2007
Issues in biomedical research data management and analysis: needs and barriersNicholas R Anderson, E Sally Lee, J Scott Brockenbrough, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|August 6, 2009
Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferationJ Scott Brockenbrough, Janice K Morihara, Stephen E Hawes, et al.
Gut|February 22, 2014
Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunityIngunn M Stromnes, J Scott Brockenbrough, Kamel Izeradjene, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumorsJ Scott Brockenbrough, Timothee Souquet, Janice K Morihara, et al.
Cancer Cell|November 4, 2015
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal AdenocarcinomaIngunn M Stromnes, Thomas M Schmitt, Ayaka Hulbert, et al.
Cancer Immunology Research|April 28, 2019
Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal AdenocarcinomaIngunn M Stromnes, Adam L Burrack, Ayaka Hulbert, et al.
Biophysical Journal|May 12, 2016
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid PhaseChristopher C DuFort, Kathleen E DelGiorno, Markus A Carlson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nucleosides, Nucleotides & Nucleic Acids|April 15, 2010
Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP)John R Grierson, J Scott Brockenbrough, Janet S Rasey, et al.
Nuclear Medicine and Biology|August 21, 2007
A simple quantitative assay for the activity of thymidine kinase 1 in solid tumorsJ Scott Brockenbrough, Janet S Rasey, John R Grierson, et al.
Nuclear Medicine and Biology|June 27, 2007
Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activityJohn R Grierson, J Scott Brockenbrough, Janet S Rasey, et al.
Journal of the American Medical Informatics Association : JAMIA|April 27, 2007
Issues in biomedical research data management and analysis: needs and barriersNicholas R Anderson, E Sally Lee, J Scott Brockenbrough, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|August 6, 2009
Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferationJ Scott Brockenbrough, Janice K Morihara, Stephen E Hawes, et al.
Gut|February 22, 2014
Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunityIngunn M Stromnes, J Scott Brockenbrough, Kamel Izeradjene, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumorsJ Scott Brockenbrough, Timothee Souquet, Janice K Morihara, et al.
Cancer Cell|November 4, 2015
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal AdenocarcinomaIngunn M Stromnes, Thomas M Schmitt, Ayaka Hulbert, et al.
Cancer Immunology Research|April 28, 2019
Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal AdenocarcinomaIngunn M Stromnes, Adam L Burrack, Ayaka Hulbert, et al.
Biophysical Journal|May 12, 2016
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid PhaseChristopher C DuFort, Kathleen E DelGiorno, Markus A Carlson, et al.
Pageof 1